09:00 Registration
09:30 Welcome, Jan van Meerbeeck, UZ Antwerpen, Belgium
09:35 Research lecture
Chair: Jan van Meerbeeck, UZ Antwerpen, Belgium
Volatomics in (lung) cancer diagnosis – Kevin Lamote, UZ Gent, Belgium
09:55 – 11.00 Session 1: Can local therapy benefit a systemic disease?
Chairs: Yolande Lievens, UZ Gent & Birgitta Hiddinga, UZ Antwerpen, Belgium
09:55 Consolidation thoracic radiotherapy in ES SCLC – Ben Slotman, VUmc, Amsterdam, the Netherlands
10:20 Prophylactic cranial irradiation in ES SCLC – Takashi Seto, National Kyushu Cancer Center, Fukuoka, Japan
10:45 Interactive Q & A with voting – Thomas Malfait, UZ Gent, Belgium
11:00 Break
11:30 – 13.00 Session 2: The winding road to cure in metastatic NSCLC
Chairs: Egbert Smit, NKI-AvL, Amsterdam, the Netherlands & Veerle Surmont, UZ Gent, Belgium
11:30 Targeting rank ligand for survival or for bone recovery? – Solange Peters, CHU Lausanne, Switzerland
11:50 2nd generation ALK-inhibitors: luxury or necessity? – Christian Rolfo, UZ Antwerpen, Belgium
12:05 2nd generation EGFR-TKI: progress or redundancy? – James Yang, Taipeh, Taiwan
12:25 3rd generation EGFR-TKI’s: drowning the fish? – Benjamin Besse, IGR, Paris, France
12:45 Will we ever cure mNSCLC? – Egbert Smit, NKI-AvL, Amsterdam, the Netherlands
13:00 Adjourn – Veerle Surmont, UZ Gent, Belgium
13:05 Buffet
